Welcome To Medicare: Pfizer Sees Part D As Key To Rebirth

The Medicare prescription drug benefit will be a key factor for energizing Pfizer's growth, CEO Hank McKinnell indicated during the Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York Jan. 4